The Asian Scientist 100
Di Li
Institution
National Astronomical Observatories of the Chinese Academy of Sciences
Country
China
Field
Aerospace & Astronomy
Li received the Marcel Grossmann Award for his pioneering contributions in the field of fast radio bursts. Li is the first scientist in China to receive this prize for research conducted within China.
(Photo: The Paper)
AWARDS
- Marcel Grossmann Award
Related articles
Placing Science At The Heart Of Society
Science cannot be done in a vacuum, but must interface with the general public, the media and politics if progress is to be sustained, said a distinguished panel of speakers at the Global Young Scientists Summit 2018.
Accounting For Complexity
Although financial analysts are sophisticated and savvy investors, even they are tripped up by the complex nature of derivatives, says Assistant Professor Hye Sun Chang of the SMU School of Accountancy.
Savior Or Villain? Investing In The Bigger Picture
Is foreign institutional investment good or bad for a firm? It depends on whose point of view you take, says SMU Assistant Professor Lou Yun.
Speaking Information, The Language Of The Markets
The capital markets hinge on financial information, and accounting researchers like SMU Assistant Professor Lou Yun are poised to decode it.
When The Public Gets Personal
Crisis communication could be improved if practitioners learn to recognise the underlying emotions behind the public’s response, says SMU Professor Augustine Pang.
7 Must-Read Stories In May 2018
Prominent personalities, therapies for HIV infection and cool feats of engineering were topics of interest in the month of May.
Akira Yoshino Wins 2018 Japan Prize For Lithium Battery Breakthrough
Dr. Akira Yoshino, President of the Lithium Ion Battery Technology and Evaluation Center at Asahi Kasei, has been awarded the 2018 Japan Prize for his invention of lithium-ion batteries.
Why A Pair Of Genes Is Just Right For Cells
Haploid and tetraploid cells under- or over-produce centrosomes and microtubules respectively, leading to instability during cell division.
Lion TCR Raises US$20 Million In Series A Funding
The funds will be used to advance clinical trials of LioCyx™, Lion TCR’s T-cell therapy against hepatocellular carcinoma.